29 related articles for article (PubMed ID: 28848075)
1. MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density.
Papin C; Ibrahim A; Sabir JSM; Le Gras S; Stoll I; Albiheyri RS; Zari AT; Bahieldin A; Bellacosa A; Bronner C; Hamiche A
J Exp Clin Cancer Res; 2023 Nov; 42(1):301. PubMed ID: 37957685
[TBL] [Abstract][Full Text] [Related]
2. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.
van Bemmel D; Lenz P; Liao LM; Baris D; Sternberg LR; Warner A; Johnson A; Jones M; Kida M; Schwenn M; Schned AR; Silverman DT; Rothman N; Moore LE
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1143-8. PubMed ID: 22539607
[TBL] [Abstract][Full Text] [Related]
3. A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells.
Bader SA; Walker M; Harrison DJ
Br J Cancer; 2007 Feb; 96(4):660-6. PubMed ID: 17285135
[TBL] [Abstract][Full Text] [Related]
4. Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma.
Valiulyte I; Steponaitis G; Skiriute D; Tamasauskas A; Vaitkiene P
BMC Med Genet; 2017 Jul; 18(1):72. PubMed ID: 28709401
[TBL] [Abstract][Full Text] [Related]
5. Role of
Li J; Ye D; Wang L; Peng Y; Li Q; Deng H; Zhou C
Onco Targets Ther; 2018; 11():651-663. PubMed ID: 29440913
[TBL] [Abstract][Full Text] [Related]
6. DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine-5 methylation.
Shao D; Liu C; Wang Y; Lin J; Cheng X; Han P; Li Z; Jian D; Nie J; Jiang M; Wei Y; Xing J; Guo Z; Wang W; Yi X; Tang H
FASEB J; 2023 Dec; 37(12):e23284. PubMed ID: 37905981
[TBL] [Abstract][Full Text] [Related]
7. Insights into MLH1 Methylation in Endometrial Adenocarcinoma through Pyrosequencing Analysis: A Retrospective Observational Study.
Silva FFVE; Ballini A; Caponio VCA; Pérez-Sayáns M; Cortés MG; Rojo-Álvarez LI; García-García A; Suaréz-Peñaranda JM; Di Domenico M; Padín-Iruegas ME
Cancers (Basel); 2024 Jun; 16(11):. PubMed ID: 38893238
[No Abstract] [Full Text] [Related]
8. Upper tract urothelial carcinoma: a different disease entity in terms of management.
Leow JJ; Chong KT; Chang SL; Bellmunt J
ESMO Open; 2016; 1(6):e000126. PubMed ID: 28848663
[TBL] [Abstract][Full Text] [Related]
9. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
[TBL] [Abstract][Full Text] [Related]
11. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
[TBL] [Abstract][Full Text] [Related]
12. Chromatin Remodeling and Epigenetic Regulation in Plant DNA Damage Repair.
Kim JH
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443358
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions.
Jasek K; Kubatka P; Samec M; Liskova A; Smejkal K; Vybohova D; Bugos O; Biskupska-Bodova K; Bielik T; Zubor P; Danko J; Adamkov M; Kwon TK; Büsselberg D
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31323834
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer.
Wojtczyk-Miaskowska A; Presler M; Michajlowski J; Matuszewski M; Schlichtholz B
Cell Physiol Biochem; 2017; 42(6):2404-2417. PubMed ID: 28848075
[TBL] [Abstract][Full Text] [Related]
15. Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.
Ma Y; Chen Y; Petersen I
Pathol Res Pract; 2017 Apr; 213(4):333-338. PubMed ID: 28214209
[TBL] [Abstract][Full Text] [Related]
16. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
[TBL] [Abstract][Full Text] [Related]
17. Changes of DNA repair gene methylation in blood of chronic fluorosis patients and rats.
Wu CX; Wang YH; Li Y; Guan ZZ; Qi XL
J Trace Elem Med Biol; 2018 Dec; 50():223-228. PubMed ID: 30262283
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
19. Identifying DNA methylation biomarkers of cancer drug response.
Maier S; Dahlstroem C; Haefliger C; Plum A; Piepenbrock C
Am J Pharmacogenomics; 2005; 5(4):223-32. PubMed ID: 16078859
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
